CLINIGMA ApS: Financial statements 2019
CVR: 39350580
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
CLINIGMA ApS (CVR 39350580) has filed annual accounts for 2019. In 2019, the company reported revenue of DKK 1,095,538 and a net result of DKK 899 compared with DKK 10,870 the year before. The profit margin was 0.1%. Equity in the 2019 report amounted to DKK 561,769. The solvency ratio was 76.7%. The company had 2 employees in the financial year.
- Revenue
- DKK 1,095,538
- Gross Profit
- DKK 348,708
- Profit/Loss
- DKK 899
- Equity
- DKK 561,769
- Total Assets
- DKK 732,196
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | 1.1 mio. | 349 t. | 899 | 562 t. | 2 |
| 2018 | - | 62 t. | 11 t. | 61 t. | 1 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
CLINIGMA ApS has published its interim report for the period February 15, 2018 – December 31, 2018.
About CLINIGMA ApS
CLINIGMA ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2018. The company is registered under the industry Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.. The company was previously named Clinical Survey Outcomes ApS. The management consists of Christian Bredmose Holm. The board consists of Rune Tarnø (chair) and Christian Bredmose Holm. The company is owned by Kongsø Gruppen ApS and CH Technologies Holding ApS. According to the 2025 annual report, the company had an average of 6 employees. In 2025, the company reported a gross profit of DKK 7,829,455 and a net result of DKK 2,200,115 compared with DKK -133,939 the year before. Equity in the 2025 report amounted to DKK 69.